Extended spectrum beta-lactamases: A therapeutic dilemma

被引:9
作者
Patterson, JE
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Med Infect Dis, San Antonio, TX 78284 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78284 USA
关键词
D O I
10.1097/00006454-200210000-00014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:957 / 959
页数:3
相关论文
共 14 条
[1]  
Diekema DJ, 1999, CLIN INFECT DIS, V29, P595, DOI 10.1086/598640
[2]   Antimicrobial resistance in intensive care units [J].
Fridkin, SK ;
Gaynes, RP .
CLINICS IN CHEST MEDICINE, 1999, 20 (02) :303-+
[3]  
Garner JS, 1996, AM J INFECT CONTROL, V24, P24
[4]  
JACOBY GA, 1999, EMERGING PATHOGENS I, P14
[5]   In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins [J].
MartinezMartinez, L ;
HernandezAlles, S ;
Alberti, S ;
Tomas, JM ;
Benedi, VJ ;
Jacoby, GA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (02) :342-348
[6]   NOSOCOMIAL OUTBREAK OF KLEBSIELLA INFECTION RESISTANT TO LATE-GENERATION CEPHALOSPORINS [J].
MEYER, KS ;
URBAN, C ;
EAGAN, JA ;
BERGER, BJ ;
RAHAL, JJ .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (05) :353-358
[7]  
Monnet DL, 1997, INFECT CONT HOSP EP, V18, P492
[8]  
National Committee for Clinical Laboratory Standards, 1998, M100S8 NAT COMM CLIN
[9]   OUTBREAK OF CEFTAZIDIME RESISTANCE DUE TO A NOVEL EXTENDED-SPECTRUM BETA-LACTAMASE IN ISOLATES FROM CANCER-PATIENTS [J].
NAUMOVSKI, L ;
QUINN, JP ;
MIYASHIRO, D ;
PATEL, M ;
BUSH, K ;
SINGER, SB ;
GRAVES, D ;
PALZKILL, T ;
ARVIN, AM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (09) :1991-1996
[10]   Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases:: Implications for the clinical microbiology laboratory [J].
Paterson, DL ;
Ko, WC ;
Von Gottberg, A ;
Casellas, JM ;
Mulazimoglu, L ;
Klugman, KP ;
Bonomo, RA ;
Rice, LB ;
McCormack, JG ;
Yu, VL .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (06) :2206-2212